How to Read a Peptide COA

Start with the complete document and sample identity

A certificate of analysis summarizes results for identified material. Begin with the laboratory name, report identifier, sample description, supplier or submitter, lot number, relevant dates, and all pages or attachments. Keep the original file and the date reviewed so that the purchasing and laboratory records point to the same document.

Match the reported material to the actual listing or received vial. Compound name, labeled presentation, disclosed formulation, and lot should be consistent. If a report covers a submitted sample, do not describe it as proof that every unit was individually tested. Ask how the sample relates to the supplied lot when that matters to the study.

Document revisions deserve the same attention as results. An amended report may replace an earlier file without changing the product’s URL. Preserve the version used for an earlier decision, identify the newer version, and record whether the change affects acceptance of the material.

Separate the analytical questions

Read the units and reporting basis beside each number. A result stated per milliliter cannot be treated as per vial without the relevant sample preparation and volume information. Similarly, “not detected” must be interpreted with the method’s detection or reporting limit; it does not mean a mathematically exact zero.

How to interpret HPLC purity

High-performance liquid chromatography separates components under a defined method, while the detector records responses over time. When a report uses area normalization, the stated purity is generally the target peak’s integrated area divided by the total included peak area, multiplied by 100. The method and integration rules determine which responses enter that calculation.

For a simple illustrative calculation, a target area of 995 units out of 1,000 total included units gives 99.5% area purity. This is an invented arithmetic example, not a BulkGLP batch result. It does not establish 9.95 mg in a nominal 10 mg vial because detector response and total vial content are different measurements.

Inspect the chromatogram, method identifier, detector or wavelength information when reported, and how peaks were assigned. Co-elution or components that the selected method does not measure can limit what the percentage represents. ICH Q2(R2) provides the broader framework for validating an analytical procedure for its intended purpose.

What LC-MS and molecular-mass results mean

Liquid chromatography coupled to mass spectrometry can connect a chromatographic component with measured ion signals. A peptide may appear in more than one charge state; the reported molecular mass may therefore involve interpretation or deconvolution rather than simply copying the largest displayed mass-to-charge number.

Compare the measured value with the expected chemical form and the laboratory’s stated tolerance. Modifications, salts, adducts, and the chosen reporting basis can affect how values should be read. Ask for the laboratory’s interpretation when the apparent match is unclear instead of trying to repair an unexplained discrepancy in a spreadsheet.

A matching mass supports identity but does not by itself prove sequence, exclude every isomer, or measure total material per container. Additional evidence may be needed for the intended question. ICH Q6A makes the related distinction that a chromatographic retention time alone is not sufficiently specific as an identity test.

Keep measured content separate from purity

A quantitative content result should identify the analyte, units, sample basis, and method used. For a vial-based result, understand whether the laboratory analyzed a whole submitted vial, an aliquot, a solution prepared by the submitter, or a pooled sample. Those are different sample histories.

A nominal label amount and a measured sample result can both be recorded without treating them as interchangeable. Record the label claim as the commercial presentation and the analytical value on its stated basis. Water, counterions, and disclosed excipients can make total solid weight different from peptide content.

When purchasing multiple containers, do not multiply a single submitted vial’s measured excess across every unit as a guaranteed quantity. Ask what sampling and quantitative evidence support the lot. If content is essential to the experiment, define the required evidence before treating the material as accepted inventory.

Endotoxin and sterility need their own evidence

An endotoxin result needs its method, sample matrix, units, limit, and interpretation. Inhibition or enhancement by the sample can matter to the method’s suitability. FDA’s March 2026 pyrogen and endotoxin guidance describes testing considerations for regulated products; linking it here does not establish that a research vial meets a clinical-use standard.

An endotoxin test does not substitute for a sterility test. Likewise, the words “sterile,” “bacteriostatic,” or “filtered” on an accessory cannot create a missing peptide test result. Record only the tests actually reported for the relevant sample.

If the report gives a value below a reporting limit, retain the less-than sign and units. Replacing “less than the stated limit” with “zero endotoxin” changes the meaning. Where the required testing is absent, mark it as unreported rather than borrowing a result from a different compound or lot.

Evaluate the laboratory and report trail

Check that the testing laboratory can be identified independently from the supplier’s product page. Where a report-verification link or identifier is provided, use it and preserve the result. A cropped image of one number is less informative than the complete report and its traceable identifier.

ISO/IEC 17025 concerns testing and calibration laboratory competence. If accreditation is claimed, check the current certificate and relevant scope with the accreditation body; a logo alone does not show that every method on a report is covered. Do not describe a supplier itself as accredited merely because it uses an outside laboratory.

For a result that affects an important research decision, resolve discrepancies in writing. A useful question identifies the exact report, sample, field, and uncertainty. Keep the laboratory or supplier response with the original file rather than rewriting the report yourself.

Use a short COA review worksheet

1. Identify the product, variation, lot and received or offered material.
2. Save the complete report, laboratory identity, report number and version.
3. Record identity, purity and content separately, including units and basis.
4. Record additional tests exactly as reported, or mark them unreported.
5. Compare results with the laboratory’s acceptance requirements.
6. Resolve missing fields or conflicting identifiers with the supplier or laboratory.
7. Document the acceptance decision and reviewer.

A COA review is strongest when another researcher can follow the same record and reach the same limited conclusion. The goal is not a blanket claim that a material is suitable for every purpose. It is a clear statement of what was tested, what the report supports, and what remains outside its scope.

A COA is one part of the material record

Connect the report to the peptide storage and shelf-life record. A sound report at one time does not erase a later storage excursion or establish an unlisted solution expiry. For procurement context, the Retatrutide sourcing guide explains how to request lot continuity and supporting documents before ordering.

Frequently asked questions

Sources and further reading

• FDA / ICH Q2(R2): analytical procedure validation
• FDA / ICH Q6A: identity and specification principles
• FDA: pyrogen and endotoxin testing, March 2026
• ISO/IEC 17025: testing laboratory competence
• BulkGLP: current and archived analytical reports